|
Volumn 13, Issue 3, 1996, Pages 445-448
|
Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females
a a a a b a a b a c |
Author keywords
Bioavailability; Gender effect; MK 0476; Montelukast sodium; Pharmacokinetics; Singulair
|
Indexed keywords
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
MONTELUKAST;
PLACEBO;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
BIOAVAILABILITY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG SAFETY;
DRUG TOLERABILITY;
GENDER;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
HUMAN EXPERIMENT;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
NORMAL HUMAN;
PHARMACOKINETICS;
PRIORITY JOURNAL;
TABLET;
VOLUNTEER;
ACETATES;
ADMINISTRATION, ORAL;
ADULT;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
INJECTIONS, INTRAVENOUS;
LEUKOTRIENE ANTAGONISTS;
MALE;
MEMBRANE PROTEINS;
PLACEBOS;
QUINOLINES;
RECEPTORS, LEUKOTRIENE;
SEX FACTORS;
|
EID: 9244265470
PISSN: 07248741
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1016056912698 Document Type: Article |
Times cited : (135)
|
References (7)
|